Skip to main content

SHISEIDO BENEFIANCE WRINKLE SMOOTHING DAY

NDC 58411-017 · Shiseido Americas Corporation

Generic nameAvobenzone, Homosalate, Octisalate, and Octocrylene
Dosage formCREAM
RouteTOPICAL
Active ingredient(s)AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE
Strength1.295; 2.331; 2.331; 2.59 g/50mL; g/50mL; g/50mL; g/50mL
Marketing categoryOTC MONOGRAPH DRUG

Packages

58411-017-50 — 1 JAR in 1 CARTON (58411-017-50) / 50 mL in 1 JAR

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

56152-5001 — Avobenzone, Homosalate, Octocrylene, Oxybenzone, 57627-107 — OCTINOXATE,OCTISALATE, 57627-108 — octinoxate, octisalate, 57627-170 — Homosalate, Octinoxate, Oxybenzone, Titanium Dioxide, 57627-186 — Avobenzone, Octocrylene, 57627-203 — Avobenzone, Octocrylene, 57627-204 — Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone, 57913-2833 — Avobenzone, Octinoxate, and Octisalate, 58331-060 — Homosalate, Octisalate, Oxybenzone,Avobenzone, Octocrylene, 58331-075 — HOMOSALATE, OCTISALATE, OXYBENZONE, AVOBENZONE, OCTOCRYLENE, 58411-018 — AVOBENZONE, HOMOSALATE, OCTISALATE, and OCTOCRYLENE, 58411-020 — Avobenzone, Octisalate, and Octocrylene, 58411-121 — OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE, 58411-122 — OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE, 58411-123 — OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE, 58411-124 — OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE, 58411-125 — OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE, 58411-126 — OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE, 58411-127 — OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE, 58411-129 — OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE, +3818 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels